These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 34448381)
1. Comprehensive Updates in the Role of Imaging for Multiple Myeloma Management Based on Recent International Guidelines. Lee K; Kim KW; Ko Y; Park HY; Chae EJ; Lee JH; Ryu JS; Chung HW Korean J Radiol; 2021 Sep; 22(9):1497-1513. PubMed ID: 34448381 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma. Westerland O; Amlani A; Kelly-Morland C; Fraczek M; Bailey K; Gleeson M; El-Najjar I; Streetly M; Bassett P; Cook GJR; Goh V; Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2558-2565. PubMed ID: 33469686 [TBL] [Abstract][Full Text] [Related]
3. Multiple Myeloma Guidelines and Their Recent Updates: Implications for Imaging. Mosebach J; Thierjung H; Schlemmer HP; Delorme S Rofo; 2019 Nov; 191(11):998-1009. PubMed ID: 31137045 [TBL] [Abstract][Full Text] [Related]
4. How do we image patients with multiple myeloma and precursor states? Chakraborty R; Hillengass J; Lentzsch S Br J Haematol; 2023 Nov; 203(4):536-545. PubMed ID: 37217164 [TBL] [Abstract][Full Text] [Related]
5. Updates and Ongoing Challenges in Imaging of Multiple Myeloma: Wu F; Bernard S; Fayad LM; Ilaslan H; Messiou C; Moulopoulos LA; Mulligan ME AJR Am J Roentgenol; 2021 Oct; 217(4):775-785. PubMed ID: 33978464 [TBL] [Abstract][Full Text] [Related]
6. The utility of ADC value in diffusion-weighted whole-body MRI in the follow-up of patients with multiple myeloma. Correlation study with Paternain A; García-Velloso MJ; Rosales JJ; Ezponda A; Soriano I; Elorz M; Rodríguez-Otero P; Aquerreta JD Eur J Radiol; 2020 Dec; 133():109403. PubMed ID: 33202373 [TBL] [Abstract][Full Text] [Related]
7. Imaging in myeloma with focus on advanced imaging techniques. Barwick T; Bretsztajn L; Wallitt K; Amiras D; Rockall A; Messiou C Br J Radiol; 2019 Mar; 92(1095):20180768. PubMed ID: 30604631 [TBL] [Abstract][Full Text] [Related]
8. Overview and recent advances in PET/CT imaging in lymphoma and multiple myeloma. Zanoni L; Mattana F; Calabrò D; Paccagnella A; Broccoli A; Nanni C; Fanti S Eur J Radiol; 2021 Aug; 141():109793. PubMed ID: 34148014 [TBL] [Abstract][Full Text] [Related]
9. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma. Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093 [TBL] [Abstract][Full Text] [Related]
13. Guidelines for the use of imaging in the management of patients with myeloma. Chantry A; Kazmi M; Barrington S; Goh V; Mulholland N; Streetly M; Lai M; Pratt G; Br J Haematol; 2017 Aug; 178(3):380-393. PubMed ID: 28677897 [TBL] [Abstract][Full Text] [Related]
14. Role of Cavo M; Terpos E; Nanni C; Moreau P; Lentzsch S; Zweegman S; Hillengass J; Engelhardt M; Usmani SZ; Vesole DH; San-Miguel J; Kumar SK; Richardson PG; Mikhael JR; da Costa FL; Dimopoulos MA; Zingaretti C; Abildgaard N; Goldschmidt H; Orlowski RZ; Chng WJ; Einsele H; Lonial S; Barlogie B; Anderson KC; Rajkumar SV; Durie BGM; Zamagni E Lancet Oncol; 2017 Apr; 18(4):e206-e217. PubMed ID: 28368259 [TBL] [Abstract][Full Text] [Related]
15. Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT. Lecouvet FE; Vekemans MC; Van Den Berghe T; Verstraete K; Kirchgesner T; Acid S; Malghem J; Wuts J; Hillengass J; Vandecaveye V; Jamar F; Gheysens O; Vande Berg BC Skeletal Radiol; 2022 Jan; 51(1):59-80. PubMed ID: 34363522 [TBL] [Abstract][Full Text] [Related]
16. Progress of modern imaging modalities in multiple myeloma. Terao T; Matsue K Int J Hematol; 2022 Jun; 115(6):778-789. PubMed ID: 35532876 [TBL] [Abstract][Full Text] [Related]
18. Symptomatic Myeloma: PET, Whole-Body MR Imaging with Diffusion-Weighted Imaging or Both. Rossi A; Cattabriga A; Bezzi D PET Clin; 2024 Oct; 19(4):525-534. PubMed ID: 38969566 [TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis. Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513 [TBL] [Abstract][Full Text] [Related]
20. Role of FDG PET in the staging of multiple myeloma. Vicentini JRT; Bredella MA Skeletal Radiol; 2022 Jan; 51(1):31-41. PubMed ID: 33813607 [No Abstract] [Full Text] [Related] [Next] [New Search]